Previous 10 | Next 10 |
2023-05-16 01:29:25 ET Summary GSK's operating income margin in Q1 2023 was 29.35%, showing an increase in the previous quarter and the last year. Vaccine sales were $2,493 million in Q1 2023, up 11.9% year-over-year, mainly due to Fluarix and FluLaval, which regulators approved t...
2023-05-11 22:42:09 ET Takeda Pharmaceutical Company Limited (TAK) Q4 2022 Results Conference Call May 11, 2023 06:00 AM ET Company Participants Christopher O’Reilly - Global Head of IR & Global Finance Christophe Weber - President, CEO & Representativ...
2023-05-11 09:37:36 ET Phathom Pharmaceuticals ( NASDAQ: PHAT ) added ~8% on Thursday morning after Evercore ISI upgraded the biopharma, citing a potential FDA approval for its initial product candidate, vonoprazan, targeted at gastrointestinal disorders. “Phathoms...
2023-05-11 07:05:23 ET Takeda Pharmaceutical ( NYSE: TAK ) FY22 revenue grew but noted that its FY2023 outlook reflects challenges from generics impact and lower COVID-19 vaccine contributions. The Japanese drugmaker's Core EPS grew +31.5% at actual % change (+13.9% at CER b...
2023-05-11 03:31:04 ET Takeda Pharmaceutical press release ( NYSE: TAK ): FY Non-GAAP EPS of ¥558.00. Revenue of ¥4.03B growth of +12.8%; Core Revenue Growth of +3.5% at Constant Exchange Rate Driven by Growth & Launch Products; Reported EPS Gro...
Full Year Reported Revenue Growth of + 12.8%; Core Revenue Growth of +3.5% at Constant Exchange Rate Driven by Growth & Launch Products; Reported EPS Growth of +38.8% Achieved Core Operating Profit of 1,188.4 Billion Yen – Exceeding 1 Trillion Yen for the First Tim ...
Takeda Presents Real-World Clinical Effectiveness and Safety Results of Vedolizumab (ENTYVIO®) and Ustekinumab as First-Line Biologic Treatment for Crohn's Disease Canada NewsWire TORONTO , May 10, 2023 /CNW/ - Takeda Canada Inc. ("Takeda") announces results...
2023-05-05 14:00:36 ET Earnings season continues next week, although the pace of releases begins to slow. Entertainment companies provide key highlights during the period, with reports due out from Disney ( DIS ) and Fox ( FOX ). Outside of media, both the pharmaceutical and EV ...
2023-05-03 06:08:01 ET The rate of drug overdose deaths involving fentanyl rose 279% between 2016 and 2021, according to a report from the U.S. Centers for Disease Control and Prevention (CDC). Fentanyl is a synthetic opioid that is up to 50 times stronger than heroin and 100 times...
2023-05-01 23:53:08 ET Summary My portfolio, built specifically for my retirement ~20 years from now, features growth, dividends, and risk stocks for a happy retirement. Great performances by Arrowhead Pharmaceuticals and Meta propelled my portfolio again to all-time highs and mar...
News, Short Squeeze, Breakout and More Instantly...
Takeda Pharmaceutical Company Limited American Depositary Shares Company Name:
TAK Stock Symbol:
NYSE Market:
Takeda Pharmaceutical Company Limited American Depositary Shares Website:
2024-07-18 10:20:00 ET July 18, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:CTXR ), a late-stage biopharmaceutical compa...
2024-07-04 20:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Takeda (TOKYO:4502/NYSE:TAK) has announced new assignments of directors, determined at the Board of Directors meeting and at the Audit and Supervisory Committee meeting, following the 148th Ordinary Meeting of Shareholders, held in Osaka today. Takeda's Board of Directors has 11 members servi...